DANAHER CORPORATION: Danaher Completes Acquisition of the BioPharma Business of General Electric Life Sciences; Business will be called Cytiva

Economics
Handshake07

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Washington D.C. Business Daily.
Community Newsmaker

Danaher Corporation issued the following announcement on March 31.

Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.

Original source can be found here.

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Washington D.C. Business Daily.
Community Newsmaker

MORE NEWS